Regenerative Medicine in Medical – Thematic Research
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Regenerative Medicine in Medical Market Thematic Overview
Regenerative medicine is an innovative field of medicine that holds the potential to fully cure diseases, eliminate cancer, and heal old and damaged tissue. Regenerative medicine is relevant to the orthopedic, cardiovascular, neurological, wound care, cancer, and pharmaceutical markets. The three main branches of regenerative medicine are gene therapy, cell therapy, and tissue repair. Currently, available gene therapies focus on curing rare diseases, but research is gaining traction in both prevalent and polygenic diseases. Market players in regenerative medicine range from large dominant corporations to small innovative start-ups. While the big-name corporations leverage their presence in relevant markets around the world, the start-ups continually develop novel technologies and expand regenerative medicine capabilities.
The Regenerative Medicine in Medical thematic intelligence report briefs about the types of regenerative medicine. It provides an overview of the current landscape, including healthcare, technology, regulatory, macroeconomic trends, and key players. The primary focus of this report is on regenerative medicine therapies that act as medical devices and are not strictly drug-related.
Report Pages | 40 |
Regions Covered | Global |
Market Size (2021) | $2.2 billion |
Key Trends | Technology, Macroeconomic, and Regulatory |
Value Chain | Gene Therapies, Cell Therapies and Tissue Repair |
Leading companies in Regenerative Medicine | Astellas Pharma, Bayer, Bristol Myers Squibb, Novartis and SanBio |
Key Trends
The main trends shaping the Regenerative Medicine space in the medical industry are classified into three categories: technology trends, macroeconomic trends, and regulatory trends.
Technology trends – The report focuses on key technology trends impacting the regenerative medicine theme, which include gene therapy, cell therapy, and tissue repair.
Macroeconomic trends – The report analyses macroeconomic trends impacting the regenerative medicine theme, which include funding and clinical trials.
Regulatory trends – The report highlights the key regulatory trends issued by countries such as the US, Europe, Japan, China, and South Korea impacting the regenerative medicine theme.
For more insights on key trends impacting regenerative medicine theme in medical industry, download a free report sample
Regenerative Medicine in Medical – Industry Analysis
Based on the tracked sales of approved regenerative medicines, GlobalData estimates that the market size in 2021 was $2.2 billion and is expected to grow at a compound annual growth rate (CAGR) of more than 40%. Regenerative medicine will provide therapeutic options for previously untreatable diseases, but each segment faces unique challenges. For instance, the gene therapy market has a couple of significant product approvals in the rare disease space. Still, the high cost of these therapies is currently hindering their widespread adoption. Cell therapy bridges an important gap in oncology therapies but requires training of the patient’s own cells, which may respond differently on a case-by-case basis. Hence, it is currently not a generalizable therapy.
The Regenerative Medicine in Medical report analyses the market size and growth forecasts of various segments of regenerative therapies. It also identifies key players who can leverage their presence in relevant markets worldwide and small innovative start-ups that continually develop novel technology and expand regenerative medicine capabilities.
The Regenerative Medicine in Medical market analysis also covers:
- Mergers and acquisitions
- Patent trends
- Social media trends
- Timeline
For more regenerative medicine in medical industry analysis, download a free report sample
Regenerative Medicine in Medical - Value Chain Analysis
GlobalData’s regenerative medicine value chain in medical industry categorized into three major segments based on the form of the therapeutic agent used. They are gene therapies, cell therapies and tissue repair.
Gene therapies:
Gene therapies offer a unique opportunity to cure patients; however, there are many technical challenges in developing gene therapies, including the host’s gene sequences, gene editing facilitators, and gene vectors. Pharmaceutical companies such as Novartis and Bluebird bio are working out payment plan details to increase patient access to these therapies. For instance, Novartis has seen success with Zolgensma globally and recently received approvals to expand its market to Australia and South Korea.
Regenerative medicine Value Chain in Medical
For more insights on the Big Data value chain in pharma, download a free report sample
Leading Companies in the Regenerative Medicine Theme
Some of the leading vendors making their mark within the regenerative medicine theme:
- Astellas Pharma
- Bayer
- Bristol Myers Squibb
- Novartis
- SanBio
To know more about leading companies associated with the regenerative medicine theme in the medical industry, download a free report sample
Scope
This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies.
The report covers the Regenerative Medicine theme.
BioMarin
Bluebird bio
Gilead
Orchard Theraputics
Celyad
Arthrex
Stryker
W.L. Gore
Vericel Corp
Bayer AG
Table of Contents
Frequently asked questions
-
What was the market size of the Regenerative Medicine in Medical sector in 2021?
The Regenerative Medicine in Medical market was valued at $2.2 billion in 2021.
-
What are the key technology trends shaping Regenerative Medicine in Medical sector?
The key technology trends impacting the regenerative medicine theme include gene therapy, cell therapy and tissue repair.
-
What are the key macroeconomic trends shaping Regenerative Medicine in Medical industry?
The macroeconomic trends impacting the regenerative medicine theme which include funding and clinical trials.
-
What are the components of value chain of Regenerative Medicine in Medical industry?
GlobalData’s regenerative medicine value chain in medical industry is split into three segments: gene therapy, cell therapy and tissue repair.
-
Which are the leading vendors of Regenerative Medicine theme in Medical industry?
Some of the vendors making their mark within Regenerative Medicine in Medical industry are Astellas Pharma, Bayer, Bristol Myers Squibb, Novartis and SanBio among others.

Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.